2-Butyl-1,6-dihydro-N,N,4-trimethyl-6-oxo-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-5-pyrimidineacetamide（CAS：503155-67-7）

 The compound has a molecular formula of C46H45N7O2, a molecular weight of 727.90, an exact mass of 727.36300, and a large molecular polar surface area (PSA) of 98.80000, as well as a high LogP value of 7.73400, which are of great significance for its application in drug synthesis. The physicochemical properties of the non-marsartan intermediate DCMP include a predicted boiling point of 882.1±75.0 °C (Predicted), a density of 1.17, and a predicted pKa value of 1.36±0.70 (Predicted). These properties are essential for understanding its behavior and stability during synthesis. The compound is usually present as a white powder and needs to be stored in an inert atmosphere, at 2-8°C, to maintain its stability. In the process of synthesizing non-marsartan, the non-marsartan intermediate DCMP is a critical step, and its quality and purity directly affect the efficacy and safety of the final product. Therefore, the production and quality control of the non-marsartan intermediate DCMP is very important for the pharmaceutical industry. The non-marsartan intermediate DCMP has a purity of up to 99% , supplied as a white powder, suitable for scientific research and commercial production. 林lin: 04-22 09:43:44 1